Fetal Hypoxia
1
Pipeline Programs
2
Companies
4
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Human BioSciencesWV - Martinsburg
1 program1
Fetal Oxygenation MeasurementsPhase 11 trial
Active Trials
Raydiant OximetryCA - San Ramon
4 programsDual fetal oxygen sensorsN/A1 trial
Fetal Pulse OximeteryN/A1 trial
GEN 3 Monitoring of FetusN/A1 trial
Fetal Oxygenation MeasurementsPHASE_1
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Human BioSciencesFetal Oxygenation Measurements
Raydiant OximetryFetal Pulse Oximetery
Raydiant OximetryDual fetal oxygen sensors
Raydiant OximetryGEN 3 Monitoring of Fetus
Clinical Trials (4)
Total enrollment: 90 patients across 4 trials
Trans-Abdominal Fetal Pulse Oximetry - EFS-IDE
Start: Apr 2024Est. completion: Oct 202535 patients
Phase 1Completed
Dual System Study: Transvaginal Fetal Pulse Oximetry Measurement Systems
Start: Dec 2025Est. completion: Apr 202615 patients
N/ARecruiting
Trans-abdominal Fetal Pulse Oximetry
Start: Jul 2022Est. completion: Nov 202331 patients
N/ATerminated
Trans-abdominal Fetal Pulse Oximetry; Tissue Light Scattering and Signal Integrity
Start: Apr 2021Est. completion: Nov 20259 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 90 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.